IP Library Granted Patent US 8,403,822
Granted Patent B2
US 8,403,822 · App. 12/389,577 · Granted Mar 26, 2013

Passive vent for brachytherapy balloon catheters

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,403,822
App. No.
12/389,577
Granted
Mar 26, 2013
Kind
B2
Abstract

Embodiments of passive vent valve devices are disclosed. One of the novel aspects of the invention is its ability to transform from a packaging configuration to a use configuration. The packaging configuration allows sterilization gases to penetrate into the device through standard valve openings as well as through vented mesh openings. Passage of gas into the device, in turn, provides a means of sterilizing all surface areas in the device. Alternatively, when the valve is placed in a use configuration, the passage of gas through the vented mesh is inhibited providing a sealed environment that functions as a valve. The invention is useful in manufacturing sterile medical devices by allowing all surfaces to communicate with the sterilizing agent when the valve is in a packaging configuration or when it is in a use configuration.

Claims (30)

1. A brachytherapy kit, said kit comprising:

a vent assembly comprising a venting body and a cap;

said venting body comprising a diametrically vented region and a threaded external luer;

said cap comprising internal threads for accepting said threaded external luer, wherein said cap has a use configuration and a packaging configuration wherein said cap substantially overlaps said vented region when in the use configuration, and wherein said cap does not substantially overlap said vented region when in the packaging configuration; and

a brachytherapy balloon assembly comprising a balloon, a catheter shaft, and a brachytherapy port, wherein said vent assembly is attached to said brachytherapy balloon assembly;

wherein said cap is configured in the packaging configuration to allow gaseous flow through said venting body to be in fluid communication with substantially all interior and exterior surface areas of said kit.

2. The brachytherapy kit of claim 1 , wherein said diametrically vented region comprises multiple individual vents.

3. The brachytherapy kit of claim 2 , wherein said vents comprise high-density polyethylene fibers, olefin fibers or polytetrafluoroethylene.

4. The brachytherapy kit of claim 2 , wherein said vents comprise a fluid impermeable membrane.

5. The brachytherapy kit of claim 4 , wherein said fluid impermeable membrane comprises a pore size greater than 0.1 micron.

6. The brachytherapy kit of claim 4 , wherein said fluid impermeable membrane allows the passage of ethylene oxide gas.

7. The brachytherapy kit of claim 4 , wherein said membrane comprises high-density polyethylene fibers, olefin fibers or polytetrafluoroethylene.

8. The brachytherapy kit of claim 1 , wherein said venting body further comprises a threaded internal luer.

9. The brachytherapy kit of claim 8 , wherein said threaded internal luer comprises a male luer connection.

10. The brachytherapy kit of claim 1 , wherein said diametrically vented region comprises a one-way valve.

11. The brachytherapy kit of claim 1 , wherein said diametrically vented region comprises a two-way valve.

12. The brachytherapy kit of claim 1 , wherein said cap comprises a captive end for receiving the venting body.

13. The brachytherapy kit of claim 12 , wherein said captive end comprises an overhanging lip.

14. A brachytherapy kit, said kit comprising:

a vent assembly comprising a venting body and a cap;

said body comprising a vent and an external luer;

said cap configured to accept said external luer, wherein said cap has a use configuration and a packaging configuration wherein said cap substantially overlaps said vent when in the use configuration, and wherein said cap does not substantially overlap said vent when in the packaging configuration;

a catheter shaft; and

a brachytherapy balloon attached to an end of said catheter shaft, wherein said vent assembly is attached to said catheter shaft;

wherein said cap is configured in the packaging configuration to allow gaseous flow through said body to be in fluid communication with substantially all interior and exterior surface areas of said kit.

15. The brachytherapy kit of claim 14 , wherein said vent assembly further comprises a one-way valve.

16. The brachytherapy kit of claim 14 , wherein said vent assembly further comprises a two-way valve.

17. The brachytherapy kit of claim 14 , wherein said vent comprises a fluid impermeable membrane.

18. The brachytherapy kit of claim 14 , wherein said cap comprises a captive end for receiving said body.

19. The brachytherapy kit of claim 18 , wherein said captive end comprises an overhanging lip.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2009
From: BENSON, MARIA; ALLAN, DONNA; OCAMPO, WALTER
To: CYTYC CORPORATION
Reel/Frame 022289/0060 →